Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 14;18(20):10806.
doi: 10.3390/ijerph182010806.

Bioprinting Technology in Skin, Heart, Pancreas and Cartilage Tissues: Progress and Challenges in Clinical Practice

Eleonora Di Piazza  1 , Elisabetta Pandolfi  1 , Ilaria Cacciotti  2 , Andrea Del Fattore  3 , Alberto Eugenio Tozzi  1 , Aurelio Secinaro  4 , Luca Borro  4
Affiliations
Review

Bioprinting Technology in Skin, Heart, Pancreas and Cartilage Tissues: Progress and Challenges in Clinical Practice

Eleonora Di Piazza et al. Int J Environ Res Public Health. .

Abstract

Bioprinting is an emerging additive manufacturing technique which shows an outstanding potential for shaping customized functional substitutes for tissue engineering. Its introduction into the clinical space in order to replace injured organs could ideally overcome the limitations faced with allografts. Presently, even though there have been years of prolific research in the field, there is a wide gap to bridge in order to bring bioprinting from "bench to bedside". This is due to the fact that bioprinted designs have not yet reached the complexity required for clinical use, nor have clear GMP (good manufacturing practices) rules or precise regulatory guidelines been established. This review provides an overview of some of the most recent and remarkable achievements for skin, heart, pancreas and cartilage bioprinting breakthroughs while highlighting the critical shortcomings for each tissue type which is keeping this technique from becoming widespread reality.

Keywords: bioprinting; cartilage; clinical applications; heart; pancreas; regenerative medicine; skin; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Article selection process.
Figure 2
Figure 2
Main bioprinting techniques for different tissue-specific applications.
See this image and copyright information in PMC

References

    1. Matai I., Kaur G., Seyedsalehi A., McClinton A., Laurencin C.T. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials. 2020;226:119536. doi: 10.1016/j.biomaterials.2019.119536. - DOI - PubMed
    1. Ma X., Liu J., Zhu W., Tang M., Lawrence N., Yu C., Goud M., Chen S. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling. Adv. Drug Deliv. Rev. 2018;132:235–251. doi: 10.1016/j.addr.2018.06.011. - DOI - PMC - PubMed
    1. Vijayavenkataraman S., Yan W.-C., Lu W.F., Wang C.-H., Fuh J.Y.H. 3D bioprinting of tissues and organs for regenerative medicine. Adv. Drug Deliv. Rev. 2018;132:296–332. doi: 10.1016/j.addr.2018.07.004. - DOI - PubMed
    1. Ozbolat I.T., Peng W., Ozbolat V. Application areas of 3D bioprinting. Drug Discov. Today. 2016;21:1257–1271. doi: 10.1016/j.drudis.2016.04.006. - DOI - PubMed
    1. Murphy S.V., Atala A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 2014;32:773–785. doi: 10.1038/nbt.2958. - DOI - PubMed

LinkOut - more resources